Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Other financing activities (2022 - 2023)

Historic Other financing activities for Atara Biotherapeutics (ATRA) over the last 2 years, with Q2 2023 value amounting to -$13000.0.

  • Atara Biotherapeutics' Other financing activities changed N/A to -$13000.0 in Q2 2023 from the same period last year, while for Sep 2024 it was -$13000.0, marking a year-over-year decrease of 10004.23%. This contributed to the annual value of -$7000.0 for FY2024, which is 4615.38% up from last year.
  • As of Q2 2023, Atara Biotherapeutics' Other financing activities stood at -$13000.0.
  • Atara Biotherapeutics' 5-year Other financing activities high stood at $30.8 million for Q4 2022, and its period low was -$104000.0 during Q1 2022.